Skip to main content
Livermore
Livermore
ZHEN

Quadrant Capital Group LLC

SEC CIK
0001650717
Latest filing
Aug 14, 2026

RVNC holding history

Revance Therapeutics, Inc. in every 13F filed by Quadrant Capital Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RVNC overviewAll 13F holders of RVNCFull Q2 2026 holdings

Shares (Q4 2024)
0
Sold out in Q4 2024
Value
$0
% of portfolio
0.0%
Quarters held
14
Since Q1 2021
Holdings of RVNC by Quadrant Capital Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20240$00.0%−434−100.0%Sold outHolders
Q3 2024434$2.25K<0.1%+434NewHolders
Q2 20240$00.0%−400−100.0%Sold outHolders
Q1 2024400$1.97K<0.1%−198−33.1%ReducedHolders
Q4 2023598$5.26K<0.1%+455+318.2%AddedHolders
Q3 2023143$1.64K<0.1%−22−13.3%ReducedHolders
Q2 2023165$4.18K<0.1%+7+4.4%AddedHolders
Q1 2023158$5.09K<0.1%−2−1.3%ReducedHolders
Q4 2022160$2.95K<0.1%−56−25.9%ReducedHolders
Q3 2022216$6.00K<0.1%00.0%UnchangedHolders
Q2 2022216$3.00K<0.1%−41−16.0%ReducedHolders
Q1 2022257$5.00K<0.1%−60−18.9%ReducedHolders
Q4 2021317$5.00K<0.1%+204+180.5%AddedHolders
Q3 2021113$3.00K<0.1%+5+4.6%AddedHolders
Q2 2021108$3.00K<0.1%−110−50.5%ReducedHolders
Q1 2021218$6.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.